Stage-directed individualized therapy in esophageal cancer

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Esophageal cancer is the eighth most common cancer worldwide, and the incidence of esophageal carcinoma is rapidly increasing. With the advent of new staging and treatment techniques, esophageal cancer can now be managed through various strategies. A good understanding of the advances and limitations of new staging techniques and how these can guide in individualizing treatment is important to improve outcomes for esophageal cancer patients. This paper outlines the recent progress in staging and treatment of esophageal cancer, with particularly attention to endoscopic techniques for early-stage esophageal cancer, multimodality treatment for locally advanced esophageal cancer, assessment of response to neoadjuvant treatment, and the role of cervical lymph node dissection. Furthermore, advances in robot-assisted surgical techniques and postoperative recovery protocols that may further improve outcomes after esophagectomy are discussed.

Original languageEnglish
Pages (from-to)50-65
Number of pages16
JournalAnnals of the New York Academy of Sciences
Volume1381
Issue number1
DOIs
Publication statusPublished - 1 Oct 2016

Keywords

  • anastomotic leakage
  • esophageal cancer
  • esophageal surgery
  • neoadjuvant chemoradiation
  • robot-assisted
  • tumor staging

Fingerprint

Dive into the research topics of 'Stage-directed individualized therapy in esophageal cancer'. Together they form a unique fingerprint.

Cite this